|
Name |
Pyranonigrin A
|
| Molecular Formula | C10H9NO5 | |
| IUPAC Name* |
(7R)-3,7-dihydroxy-2-[(E)-prop-1-enyl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione
|
|
| SMILES |
C/C=C/C1=C(C(=O)C2=C(O1)[C@H](NC2=O)O)O
|
|
| InChI |
InChI=1S/C10H9NO5/c1-2-3-4-6(12)7(13)5-8(16-4)10(15)11-9(5)14/h2-3,10,12,15H,1H3,(H,11,14)/b3-2+/t10-/m1/s1
|
|
| InChIKey |
OALBJWDVDNROSF-VMZHVLLKSA-N
|
|
| Synonyms |
Pyranonigrin A; 773855-65-5; Pyrano[3,2-b]pyrrole-3,7-dione, 1,2-dihydro-2,6-dihydroxy-5-(1E)-1-propenyl-, (2R)- (9CI); (7R)-6,7-dihydro-3,7-dihydroxy-2-(1E)-1-propen-1-yl-pyrano[2,3-c]pyrrole-4,5-dione; 7-hydroxy Pyranonigrin S; CHEBI:133779; DTXSID501017485; ZINC95909040; HY-126604; CS-0105857; (7R)-3,7-dihydroxy-2-[(1E)-prop-1-en-1-yl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione; (7R)-3,7-dihydroxy-2-[(E)-prop-1-enyl]-6,7-dihydropyrano[2,3-c]pyrrole-4,5-dione
|
|
| CAS | 773855-65-5 | |
| PubChem CID | 16756786 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 223.18 | ALogp: | -0.5 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 95.9 | Aromatic Rings: | 2 |
| Heavy Atoms: | 16 | QED Weighted: | 0.644 |
| Caco-2 Permeability: | -4.921 | MDCK Permeability: | 0.00001270 |
| Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.005 |
| Human Intestinal Absorption (HIA): | 0.049 | 20% Bioavailability (F20%): | 0.005 |
| 30% Bioavailability (F30%): | 0.036 |
| Blood-Brain-Barrier Penetration (BBB): | 0.029 | Plasma Protein Binding (PPB): | 86.49% |
| Volume Distribution (VD): | 0.854 | Fu: | 11.90% |
| CYP1A2-inhibitor: | 0.362 | CYP1A2-substrate: | 0.769 |
| CYP2C19-inhibitor: | 0.033 | CYP2C19-substrate: | 0.054 |
| CYP2C9-inhibitor: | 0.167 | CYP2C9-substrate: | 0.787 |
| CYP2D6-inhibitor: | 0.121 | CYP2D6-substrate: | 0.293 |
| CYP3A4-inhibitor: | 0.049 | CYP3A4-substrate: | 0.046 |
| Clearance (CL): | 5.254 | Half-life (T1/2): | 0.924 |
| hERG Blockers: | 0.002 | Human Hepatotoxicity (H-HT): | 0.915 |
| Drug-inuced Liver Injury (DILI): | 0.991 | AMES Toxicity: | 0.079 |
| Rat Oral Acute Toxicity: | 0.624 | Maximum Recommended Daily Dose: | 0.209 |
| Skin Sensitization: | 0.792 | Carcinogencity: | 0.871 |
| Eye Corrosion: | 0.053 | Eye Irritation: | 0.55 |
| Respiratory Toxicity: | 0.213 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002385 | ![]() |
0.585 | D03TGJ | ![]() |
0.198 | ||
| ENC001753 | ![]() |
0.328 | D0YX4S | ![]() |
0.194 | ||
| ENC006074 | ![]() |
0.279 | D0YH0N | ![]() |
0.193 | ||
| ENC004404 | ![]() |
0.279 | D03KXY | ![]() |
0.189 | ||
| ENC001843 | ![]() |
0.263 | D0CL9S | ![]() |
0.187 | ||
| ENC004924 | ![]() |
0.262 | D0R2KF | ![]() |
0.175 | ||
| ENC004982 | ![]() |
0.261 | D09PZO | ![]() |
0.171 | ||
| ENC003039 | ![]() |
0.261 | D0TS1Z | ![]() |
0.171 | ||
| ENC003951 | ![]() |
0.260 | D0K8KX | ![]() |
0.170 | ||
| ENC002929 | ![]() |
0.258 | D07MGA | ![]() |
0.169 | ||